| Vincent Ho, | |
|
3410 W 3rd St, Los Angeles, CA 90020-1622 | |
| (213) 480-3112 | |
| Not Available |
| Full Name | Vincent Ho |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 3410 W 3rd St, Los Angeles, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013301704 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 49284 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Vincent Ho, 3015 Gainsborough Dr, Pasadena, CA 91107-5509 Ph: (626) 716-6683 | Vincent Ho, 3410 W 3rd St, Los Angeles, CA 90020-1622 Ph: (213) 480-3112 |
News Archive
Noting "the 2013 Sahel Regional Strategy calls for $1.66 billion to help meet humanitarian needs and build up resilience among vulnerable groups - an identical figure to the 2012 crisis appeal - even though aid agencies estimate the number of Sahelians at risk of going hungry this year has dropped 44 percent to 10.3 million," IRIN examines "why the ask has remained constant."
Scientists have discovered a previously unrecognized way that degradation can occur in silicone-urethane plastics that are often considered for use in medical devices. Their study, published in ACS' journal Macromolecules, could have implications for device manufacturers considering use of these plastics in the design of some implantable devices, including cardiac defibrillation leads.
The American Association of Colleges of Pharmacy, in partnership with the U.S. Food and Drug Administration and the Office of Pharmacy Affairs in the Health Resources and Services Administration, has completed a baseline evaluation of the integration of the "Science of Safety" into the curriculum of the Doctor of Pharmacy degree at accredited colleges and schools of pharmacy.
The National Institute for Health and Clinical Excellence (Nice) issued new draft guidance recommending fingolimod (brand name Gilenya) on the NHS for some patients with a form of MS. The new drug can help reduce the number of relapses in adults with highly active relapsing-remitting multiple sclerosis (RRMS), which is characterized by periods when symptoms worsen and then improve.
› Verified 4 days ago
Robert W Cheung, PHARM. D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3550 S La Brea Ave, Los Angeles, CA 90016 Phone: 323-293-9397 | |
Mrs. Afaf Guirguis Karanany, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4044 Eagle Rock Blvd, Los Angeles, CA 90065 Phone: 323-254-8642 | |
Dr. Stephanie Mary Liang Luo, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1520 San Pablo St, Los Angeles, CA 90089 Phone: 213-486-8652 | |
Mr. Benjamin S Kaster, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 11340 Iowa Ave Apt 8, Los Angeles, CA 90025 Phone: 310-478-6179 Fax: 310-478-6179 | |
Sarah Kim, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 11321 National Blvd, Los Angeles, CA 90064 Phone: 310-479-5729 | |
Linda Han, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 6041 Cadillac Ave, Kaiser West Los Angeles Medical Center, Los Angeles, CA 90034 Phone: 323-857-3989 | |
Dr. John Ball, PHARMACIST (PHARMD) Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3400 Whittier Blvd, Los Angeles, CA 90023 Phone: 562-773-3285 Fax: 323-268-1940 |